{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T17:14:49Z","timestamp":1790788489725,"version":"4.1.0"},"reference-count":22,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Nuclear Medicine and Biology"],"published-print":{"date-parts":[[2022,11]]},"DOI":"10.1016\/j.nucmedbio.2022.05.001","type":"journal-article","created":{"date-parts":[[2022,5,20]],"date-time":"2022-05-20T12:24:28Z","timestamp":1653049468000},"page":"143-150","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"special_numbering":"C","title":["Radiosynthesis and initial preclinical evaluation of [11C]AZD1283 as a potential P2Y12R PET radiotracer"],"prefix":"10.1016","volume":"114-115","author":[{"given":"Isaac M.","family":"Jackson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pablo J.","family":"Buccino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E. Carmen","family":"Azevedo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mackenzie L.","family":"Carlson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Audrey S.Z.","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emily M.","family":"Deal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mausam","family":"Kalita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samantha T.","family":"Reyes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xia","family":"Shao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Corinne","family":"Beinat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sydney C.","family":"Nagy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aisling M.","family":"Chaney","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David A.","family":"Anders","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter J.H.","family":"Scott","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bin","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michelle L.","family":"James","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.nucmedbio.2022.05.001_bb0005","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1038\/nn1997","article-title":"Microglia: active sensor and versatile effector cells in the normal and pathologic brain","volume":"10","author":"Hanisch","year":"2007","journal-title":"Nat Neurosci"},{"key":"10.1016\/j.nucmedbio.2022.05.001_bb0010","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.bbi.2013.12.010","article-title":"Dynamic structural remodelling of microglia in health and disease: a review of the models, the signals and the mechanisms","volume":"37","author":"Walker","year":"2014","journal-title":"Brain Behav Immun"},{"key":"10.1016\/j.nucmedbio.2022.05.001_bb0015","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.2967\/jnumed.119.229443","article-title":"Neuroinflammation PET imaging: current opinion and future directions","volume":"61","author":"Jain","year":"2020","journal-title":"J Nucl Med"},{"key":"10.1016\/j.nucmedbio.2022.05.001_bb0020","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/jcbfm.2011.147","article-title":"An 18-kDa translocator protein (TSPO) polymorphism explains differences in binding affinity of the PET radioligand PBR28","volume":"32","author":"Owen","year":"2012","journal-title":"J Cereb Blood Flow Metab"},{"key":"10.1016\/j.nucmedbio.2022.05.001_bb0025","doi-asserted-by":"crossref","first-page":"1512","DOI":"10.1038\/nn1805","article-title":"The P2Y12 receptor regulates microglial activation by extracellular nucleotides","volume":"9","author":"Haynes","year":"2006","journal-title":"Nat Neurosci"},{"key":"10.1016\/j.nucmedbio.2022.05.001_bb0030","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1038\/nn.3599","article-title":"Identification of a unique TGF-\u03b2-dependent molecular and functional signature in microglia","volume":"17","author":"Butovsky","year":"2014","journal-title":"Nat Neurosci"},{"key":"10.1016\/j.nucmedbio.2022.05.001_bb0035","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.bbi.2015.11.007","article-title":"Microglial P2Y12 receptors regulate microglial activation and surveillance during neuropathic pain","volume":"55","author":"Gu","year":"2016","journal-title":"Brain Behav Immun"},{"key":"10.1016\/j.nucmedbio.2022.05.001_bb0040","unstructured":"Atassi MZ. Protein Reviews Series Editor. vol. 19. n.d."},{"key":"10.1016\/j.nucmedbio.2022.05.001_bb0045","doi-asserted-by":"crossref","DOI":"10.1038\/s41419-019-1425-4","article-title":"P2Y12 regulates microglia activation and excitatory synaptic transmission in spinal lamina II neurons during neuropathic pain in rodents","volume":"10","author":"Yu","year":"2019","journal-title":"Cell Death Dis"},{"key":"10.1016\/j.nucmedbio.2022.05.001_bb0050","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1002\/glia.23097","article-title":"P2Y12 receptor is expressed on human microglia under physiological conditions throughout development and is sensitive to neuroinflammatory diseases","volume":"65","author":"Mildner","year":"2017","journal-title":"Glia"},{"key":"10.1016\/j.nucmedbio.2022.05.001_bb0055","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21020678","article-title":"Patterns of expression of purinergic receptor P2RY12, a putative marker for non-activated microglia, in aged and alzheimer\u2019s disease brains","volume":"21","author":"Walker","year":"2020","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.nucmedbio.2022.05.001_bb0060","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1007\/s00401-016-1630-5","article-title":"Soluble phospho-tau from Alzheimer\u2019s disease hippocampus drives microglial degeneration","volume":"132","author":"Sanchez-Mejias","year":"2016","journal-title":"Acta Neuropathol"},{"key":"10.1016\/j.nucmedbio.2022.05.001_bb0065","doi-asserted-by":"crossref","DOI":"10.1155\/2014\/975849","article-title":"P2Yreceptor on the verge of a neuroinflammatory breakdown","volume":"2014","author":"Amadio","year":"2014","journal-title":"Mediators Inflamm"},{"key":"10.1016\/j.nucmedbio.2022.05.001_bb0070","doi-asserted-by":"crossref","first-page":"1900","DOI":"10.1093\/brain\/awx113","article-title":"Loss of \u201chomeostatic\u201d microglia and patterns of their activation in active multiple sclerosis","volume":"140","author":"Zrzavy","year":"2017","journal-title":"Brain"},{"key":"10.1016\/j.nucmedbio.2022.05.001_bb0075","doi-asserted-by":"crossref","DOI":"10.1186\/s12974-017-1034-z","article-title":"Purinergic receptors P2Y12R and P2X7R: potential targets for PET imaging of microglia phenotypes in multiple sclerosis","volume":"14","author":"Beaino","year":"2017","journal-title":"J Neuroinflammation"},{"key":"10.1016\/j.nucmedbio.2022.05.001_bb0080","doi-asserted-by":"crossref","first-page":"5400","DOI":"10.7150\/thno.25572","article-title":"Identification of new molecular targets for PET imaging of the microglial anti-inflammatory activation state","volume":"8","author":"Villa","year":"2018","journal-title":"Theranostics"},{"key":"10.1016\/j.nucmedbio.2022.05.001_bb0085","doi-asserted-by":"crossref","first-page":"4465","DOI":"10.1021\/acschemneuro.1c00641","article-title":"Novel thienopyrimidine-based PET tracers for P2Y12Receptor imaging in the brain","volume":"12","author":"Van Der Wildt","year":"2021","journal-title":"ACS Chem Nerosci"},{"key":"10.1016\/j.nucmedbio.2022.05.001_bb0090","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1016\/j.ejmech.2013.04.007","article-title":"Synthesis, structure-property relationships and pharmacokinetic evaluation of ethyl 6-aminonicotinate sulfonylureas as antagonists of the P2Y12 receptor","volume":"65","author":"Bach","year":"2013","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.nucmedbio.2022.05.001_bb0095","doi-asserted-by":"crossref","first-page":"7015","DOI":"10.1021\/jm400820m","article-title":"Lead optimization of ethyl 6-aminonicotinate acyl sulfonamides as antagonists of the P2Y12 receptor. Separation of the antithrombotic effect and bleeding for candidate drug AZD1283","volume":"56","author":"Bach","year":"2013","journal-title":"J Med Chem"},{"key":"10.1016\/j.nucmedbio.2022.05.001_bb0100","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1021\/cn100008c","article-title":"Moving beyond rules: the development of a central nervous system multiparameter optimization (CNS MPO) approach to enable alignment of druglike properties","volume":"1","author":"Wager","year":"2010","journal-title":"ACS Chem Nerosci"},{"key":"10.1016\/j.nucmedbio.2022.05.001_bb0105","doi-asserted-by":"crossref","first-page":"2413","DOI":"10.1111\/bph.15005","article-title":"Update of P2Y receptor pharmacology: IUPHAR review 27","volume":"177","author":"Jacobson","year":"2020","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.nucmedbio.2022.05.001_bb0110","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/j.nucmedbio.2014.03.025","article-title":"Synthesis and evaluation of [11C]PyrATP-1, a novel radiotracer for PET imaging of glycogen synthase kinase-3\u03b2 (GSK-3\u03b2)","volume":"41","author":"Cole","year":"2014","journal-title":"Nucl Med Biol"}],"container-title":["Nuclear Medicine and Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S096980512200049X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S096980512200049X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T04:32:00Z","timestamp":1760848320000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S096980512200049X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11]]},"references-count":22,"alternative-id":["S096980512200049X"],"URL":"https:\/\/doi.org\/10.1016\/j.nucmedbio.2022.05.001","relation":{},"ISSN":["0969-8051"],"issn-type":[{"value":"0969-8051","type":"print"}],"subject":[],"published":{"date-parts":[[2022,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Radiosynthesis and initial preclinical evaluation of [11C]AZD1283 as a potential P2Y12R PET radiotracer","name":"articletitle","label":"Article Title"},{"value":"Nuclear Medicine and Biology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nucmedbio.2022.05.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}